Blueprint Medicines Corporation BPMC announced that the FDA placed a partial clinical hold on the phase I/II study of pipeline candidate BLU-222. The company is developing investigational inhibitor, ...

We’re nearing the start of the holiday season — in fact, there’s a good chance some of your neighbors already have lights and decorations already up. For many Americans, this time of year is marked by ...

Blueprint Medicines Corporation BPMC announced top-line data from part 2 of the PIONEER study, which evaluated its marketed drug, Ayvakit (avapritinib) for treating patients with non-advanced systemic ...

The U.S. Department of Energy (DOE) has released the Solar Futures Study detailing the significant role solar will play in decarbonizing the nation’s power grid. The study shows that by 2035, solar ...

Researchers at the Center for Genomic Regulation (CRG) in Barcelona have created the first blueprint of the human spliceosome, the most complex and intricate molecular machine inside every cell. The ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. Looking ahead to ...